Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group

S L Kenyon, D J Taylor, W Tarnow-Mordi, ORACLE Collaboration

    Research output: Contribution to journalArticlepeer-review

    453 Citations (Scopus)

    Abstract

    Preterm, prelabour rupture of the fetal membranes (pPROM) is the commonest antecedent of preterm birth, and can lead to death, neonatal disease, and long-term disability. Previous small trials of antibiotics for pPROM suggested some health benefits for the neonate, but the results were inconclusive. We did a randomised multicentre trial to try to resolve this issue.
    Original languageEnglish
    Pages (from-to)979-88
    Number of pages10
    JournalLancet
    Volume357
    Issue number9261
    Publication statusPublished - 31 Mar 2001

    Keywords

    • Adult
    • Amoxicillin-Potassium Clavulanate Combination
    • Anti-Bacterial Agents
    • Drug Therapy, Combination
    • Enterocolitis, Necrotizing
    • Erythromycin
    • Female
    • Fetal Membranes, Premature Rupture
    • Humans
    • Infant, Newborn
    • Obstetric Labor, Premature
    • Pregnancy
    • Pregnancy Outcome
    • Treatment Outcome

    Fingerprint

    Dive into the research topics of 'Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group'. Together they form a unique fingerprint.

    Cite this